University of Oxford Vaccinology in Africa 2021 – Virtual Master’s Level Course

Spread the love

Applications are open for the Vaccinology in Africa 2021 – Virtual Master’s Level Course

Application Deadline: 31st August 2021

University of Oxford Vaccinology in Africa

About the Vaccinology in Africa Award:

Overview

This course has been developed in close collaboration with leading clinicians, veterinarians and industrial partners in vaccinology.

Get Up to $100,000 Student Loan for Your Master in US or Canada - See if you are eligible

Got Admission to Study in US or Canada? See if you are eligible for international student loan

The Programme provides state-of-the-art teaching in both human and veterinary vaccinology, drawing on the experience of the Jenner Institute at the University of Oxford, The Pirbright Institute, and the course’s virtual co-host, the KEMRI Wellcome Trust Research Programme in Kenya.

These courses alternate between East and West Africa. In 2021, participation is limited to attendants currently working or studying in East Africa.

Attendance is free to participants. Places are limited and participants will be selected based on their relevant experience and background within the vaccine field, as detailed in the application form below.

Vaccinology in Africa Programme details

Each day is delivered as five one-hour sessions, with half-hour breaks in between and a one-hour lunch break.

There will also be dedicated time at the end of each day for a Q&A session with the speakers of the day.

The below programme is provisional and may be subject to change.

Day 1 – Principles of Vaccinology

  • Opening keynote: Vaccine R&D and manufacturing in Africa 
  • Introduction to vaccine design & structural vaccinology
  • Vaccine Immunology
  • New vaccine vectors and VLPs 
  •  Veterinary vaccines – latest technologies

Day 2 – Principles of Vaccinology

  • RNA technologies in vaccine design
  • Protein expression vaccine technologies
  • Nutrition and vaccine responses 
  • Maternal Immunisation
  • Virtual workshop on Vaccine Design 

Day 3 – Vaccine Technologies and their Development 

  • Progress with pneumococcal vaccines  
  • Foot-and-Mouth Disease Virus: Vaccine Research to Commercial Development
  • Development of a One Health vaccine against Rift Valley Fever
  • Progress with meningococcal vaccines  

Day 4 – Vaccine Technologies and their Development 

  • Design and pre-clinical testing of a Covid-19 vaccine and other outbreak pathogen vaccines
  • Clinical development of a COVID-19 vaccine
  • Vaccine manufacturing: General principles and case study from COVID-19
  • Developing a vaccine against Ebola
  • Subunit vaccine technology: Developing a vaccine against African swine fever

Day 5 – Major Vaccine Targets

  • HIV vaccines
  • TB Vaccines
  • Vaccination against East Coast Fever and CBPP 
  • Yellow Fever and other vaccine R&D at Institut Pasteur de Dakar 
  • Arboviral vaccines 

Day 6 – Major Vaccine Targets 

  • Poxvirus diseases of livestock 
  • Malaria vaccines 
  • Controlled Human Malaria Infection studies in Africa
  • HPV vaccines
  • Vaccines for enteric pathogens  

Day 7 – Vaccine Development, Policy and Clinical Trials 

  • Vaccine development in Africa: preclinical to field trials
  • Immunomonitoring in clinical vaccine trials
  • Developing a field trial site: Ghana 
  • Undertaking trials of new vaccines in Africa and their public engagement challenges
  • Regulation and oversight of clinical vaccine trials in Africa

Day 8 – Vaccine Development, Policy and Clinical Trials 

  • Veterinary Vaccine Development in Africa
  • Capacity building for biomedical research in Africa
  • Research & career perspectives from the pharma industry
  • Vaccines research funding policy in Africa
  • Vaccine access and cost-effectiveness in Africa

Day 9 – Vaccine Development in Africa​

  • Human vaccine development and manufacturing in South Africa
  • Strengthening innovation systems and IP development in Africa
  • Statistical analysis of vaccine trials
  • Priorities for veterinary vaccine development in Africa
  • Building capacity for human vaccine manufacturing in Africa – a strategic and funding perspective

Day 10 – Vaccine Development In Africa

  • Livestock vaccines for Africa: a manufacturing outlook
  • Accelerating vaccine research in Africa 
  • Practical, regulatory and ethical issues in vaccine development & deployment: the Kenya experience
  • Careers in vaccine R&D in Africa
  • Discussion Panel: Career and funding opportunities for vaccine researchers in Africa and beyond

Type:

Short Course

Eligibility:

You must currently be working or studying in East Africa to apply for this course. Places are limited and participants will be selected based on their relevant experience and background within the vaccine field.

Eligible Countries:

East African countries

To be Taken at (Country):

Online

Number of Awards:

Not specified

Value of Vaccinology in Africa Award:

Certification

Participants who satisfy the course requirements will receive a University of Oxford electronic certificate of attendance. To receive a certificate at the end of the course you will need to achieve a minimum attendance of 75% of the online sessions.

Attendance will be monitored throughout the sessions.

The certificate will show your name, the course title and the dates of the course you attended.

Fees

Attendance is free to all participants

Duration of Award:

How to Apply: Attendance is free to participants. Places are limited and participants will be selected based on their relevant experience and background within the vaccine field, as detailed in the application form below.

  • It is important to go through all application requirements in the Award Webpage (see Link below) before applying.
  • GOODLUCK

Visit Vaccinology in Africa Award Webpage for Details

Author

  • Ifeoma Chuks is a naturally-skilled writer. She has written and contributed to more than 6000 articles all over the internet that have formed solid experiences for particularly aspiring, young people around the globe.

    Content Manager
72920